Phase I/II clinical trial of nivolumab in combination with oligo-fractionated irradiation for unresectable advanced or recurrent gastric cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Phase I/II clinical trial of nivolumab in combination with oligo-fractionated irradiation for unresectable advanced or recurrent gastric cancer ; volume:3 ; number:1 ; day:15 ; month:8 ; year:2023 ; pages:1-7 ; date:12.2023
Communications medicine ; 3, Heft 1 (15.8.2023), 1-7, 12.2023
- Urheber
-
Mimura, Kosaku
Ogata, Takashi
Yoshimoto, Yuya
Yoshida, Daisaku
Nakajima, Shotaro
Sato, Hisashi
Machida, Nozomu
Yamada, Takanobu
Watanabe, Yohei
Tamaki, Tomoaki
Fujikawa, Hirohito
Inokuchi, Yasuhiro
Hayase, Suguru
Hanayama, Hiroyuki
Saze, Zenichiro
Katoh, Hiroyuki
Takahashi, Fumiaki
Oshima, Takashi
Suzuki, Yoshiyuki
Kono, Koji
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s43856-023-00343-4
- URN
-
urn:nbn:de:101:1-2023110310400421048496
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mimura, Kosaku
- Ogata, Takashi
- Yoshimoto, Yuya
- Yoshida, Daisaku
- Nakajima, Shotaro
- Sato, Hisashi
- Machida, Nozomu
- Yamada, Takanobu
- Watanabe, Yohei
- Tamaki, Tomoaki
- Fujikawa, Hirohito
- Inokuchi, Yasuhiro
- Hayase, Suguru
- Hanayama, Hiroyuki
- Saze, Zenichiro
- Katoh, Hiroyuki
- Takahashi, Fumiaki
- Oshima, Takashi
- Suzuki, Yoshiyuki
- Kono, Koji
- SpringerLink (Online service)
Ähnliche Objekte (12)
Extended total gastrectomy after nivolumab for unresectable multivisceral invasive gastric cancer
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial
Nivolumab plus Ipilimumab: A Novel First-Line Combination Immunotherapy for Unresectable Hepatocellular Carcinoma
First-line nivolumab plus ipilimumab for unresectable MPM in China: a cost-effectiveness analysis
Intraoperative irradiation in breast cancer: preliminary results in 80 patients as partial breast irradiation or anticipated boost prior to hypo-fractionated whole breast irradiation
Colony-stimulating factor 1 receptor blockade prevents fractionated whole-brain irradiation-induced memory deficits
Accumulation of DNA double strand breaks in normal tissues after fractionated low dose irradiation
Accumulation of DNA methylation alterations in paediatric glioma stem cells following fractionated dose irradiation
Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation
Local recurrence of breast cancer: conventionally fractionated partial external beam re-irradiation with curative intention
Release of monocyte migration signals by breast cancer cell lines after ablative and fractionated γ-irradiation
Estimation of repair parameters in mouse lip mucosa during continuous and fractionated low dose-rate irradiation
Extended total gastrectomy after nivolumab for unresectable multivisceral invasive gastric cancer
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial
Nivolumab plus Ipilimumab: A Novel First-Line Combination Immunotherapy for Unresectable Hepatocellular Carcinoma
First-line nivolumab plus ipilimumab for unresectable MPM in China: a cost-effectiveness analysis
Intraoperative irradiation in breast cancer: preliminary results in 80 patients as partial breast irradiation or anticipated boost prior to hypo-fractionated whole breast irradiation
Colony-stimulating factor 1 receptor blockade prevents fractionated whole-brain irradiation-induced memory deficits
Accumulation of DNA double strand breaks in normal tissues after fractionated low dose irradiation
Accumulation of DNA methylation alterations in paediatric glioma stem cells following fractionated dose irradiation
Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation
Local recurrence of breast cancer: conventionally fractionated partial external beam re-irradiation with curative intention
Release of monocyte migration signals by breast cancer cell lines after ablative and fractionated γ-irradiation
Estimation of repair parameters in mouse lip mucosa during continuous and fractionated low dose-rate irradiation
Extended total gastrectomy after nivolumab for unresectable multivisceral invasive gastric cancer
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial
Nivolumab plus Ipilimumab: A Novel First-Line Combination Immunotherapy for Unresectable Hepatocellular Carcinoma
First-line nivolumab plus ipilimumab for unresectable MPM in China: a cost-effectiveness analysis
Intraoperative irradiation in breast cancer: preliminary results in 80 patients as partial breast irradiation or anticipated boost prior to hypo-fractionated whole breast irradiation
Colony-stimulating factor 1 receptor blockade prevents fractionated whole-brain irradiation-induced memory deficits
Accumulation of DNA double strand breaks in normal tissues after fractionated low dose irradiation
Accumulation of DNA methylation alterations in paediatric glioma stem cells following fractionated dose irradiation
Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation
Local recurrence of breast cancer: conventionally fractionated partial external beam re-irradiation with curative intention
Release of monocyte migration signals by breast cancer cell lines after ablative and fractionated γ-irradiation